Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||||
| Depreciation Amortization | 23 | 22 | 22 | 22 |
| Accounts receivable | -178 | -40 | -6 | -58 |
| Other Working Capital | 90 | 710 | 174 | 151 |
| Other Operating Activity | -1,514 | -1,230 | -529 | -504 |
| Operating Cash Flow | $-1,579 | $-538 | $-339 | $-390 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -9 | 0 | 0 | -3 |
| Other Investing Activity | 58 | -58 | 0 | -7 |
| Investing Cash Flow | $49 | $-58 | $0 | $-10 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 2,312 | N/A | N/A | 0 |
| Common Stock Issued | 0 | 0 | 0 | 100 |
| Other Financing Activity | -296 | 9,757 | 0 | -21 |
| Financing Cash Flow | $2,016 | $9,757 | $0 | $79 |
| Beginning Cash Position | 11,179 | 2,018 | 2,357 | 2,678 |
| End Cash Position | 11,665 | 11,179 | 2,018 | 2,357 |
| Net Cash Flow | $486 | $9,161 | $-339 | $-321 |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,579 | -538 | -339 | -390 |
| Capital Expenditure | N/A | N/A | N/A | -10 |
| Free Cash Flow | -1,579 | -538 | -339 | -400 |